Nitroglycerin (NTG) Model Development Service
Are you currently facing long drug development cycles, challenges in validating novel therapeutics, or difficulty in obtaining translatable preclinical data? Our Nitroglycerin (NTG) model development service helps you accelerate drug discovery, obtain highly predictive data, and streamline preclinical validation through advanced preclinical modeling, comprehensive assessment platforms, and expert scientific guidance.
The NTG model development service leverages a well-established pharmacological tool for inducing reproducible migraine-like symptoms and studying acute cardiovascular responses. Research consistently demonstrates NTG's ability to activate trigeminal pathways, induce neuroinflammation, and alter hemodynamics, mirroring clinical conditions. This makes it a powerful model for understanding disease mechanisms and evaluating therapeutic efficacy. Creative Biolabs utilizes this robust platform to provide highly relevant preclinical data.
How Our NTG Model Development Service Can Assist Your Project
At CBL, our NTG model development service provides precise, translatable data and robust solutions for your drug discovery projects. We deliver validated insights into compound efficacy against migraine and cardiovascular conditions, offering clear mechanistic understanding to guide your therapeutic development. Our capabilities are designed to streamline your preclinical phase, ensuring your project moves forward with confidence.
Discover How We Can Help - Request a Consultation.
Workflow
Our comprehensive workflow is designed for efficiency, transparency, and scientific rigor, ensuring optimal outcomes for your research.
- Required Starting Materials:
To initiate your project, we typically require:
- Target Compound Information: Detailed chemical structure, purity, solubility data, and any known preliminary pharmacological profiles.
- Specific Research Questions/Hypotheses: Clear articulation of your study objectives and the precise questions you aim to answer.
- Desired Endpoints: Identification of key behavioral, molecular, or physiological outcomes critical for your compound's evaluation.
- Final Deliverables:
Upon completion of the service, clients receive:
- Detailed Study Reports: Comprehensive documentation of all experimental procedures, results, and analyses.
- Raw and Analyzed Data Sets: All quantitative and qualitative data in a readily accessible format for your internal review.
- Mechanistic Insights & Recommendations: Expert interpretation of findings, highlighting potential mechanisms of action and strategic advice for future development.
- Estimated Timeframe:
The typical timeframe for this service ranges from 4 to 12 weeks, depending on the complexity of the chosen NTG model, the number of compounds to be tested, and the specific endpoints incorporated into the study design.
Why Choose Us?
Choosing CBL for your NTG model development service means partnering with a leader in preclinical research, committed to accelerating your drug discovery journey. Our unique strengths and proven track record set us apart.
Key Advantages:
- Unrivaled Expertise: Benefit from over two decades of specialized experience in complex biological modeling and drug discovery, ensuring scientifically sound and impactful results.
- Translational Fidelity: Our models are meticulously designed and validated to ensure high predictability of human outcomes, de-risking your development pipeline.
- Customized Protocols: We offer highly flexible and bespoke study designs, adapting our services to precisely match your unique research questions and therapeutic targets.
- Comprehensive Assessment: Utilizing state-of-the-art facilities and a broad array of assessment tools, we provide deep mechanistic insights into your compound's effects.
- Strategic Partnership: We act as an integrated extension of your team, offering proactive communication, expert guidance, and collaborative support throughout your project.
Experience the Advantage - Get a Quote Today.
Nitroglycerin (NTG) Model
The NTG model stands as a cornerstone in preclinical research, particularly for its utility in neuroscience and cardiovascular studies. Its foundation lies in NTG's role as a potent nitric oxide (NO) donor, which mediates a cascade of physiological effects.
Precision in Migraine Research
For decades, NTG has been the gold standard for inducing migraine-like headaches in both clinical and preclinical settings. Its ability to trigger symptoms indistinguishable from spontaneous migraine attacks in susceptible individuals, and to elicit robust, reproducible phenotypes in rodent models, is unparalleled. The mechanism involves the release of nitric oxide, leading to vasodilation, activation of inflammatory pathways, and sensitization of pain-processing structures, particularly within the trigeminal nervous system. This is supported by the consistent observation of increased levels of migraine-related neurotransmitters like calcitonin gene-related peptide (CGRP) following NTG administration. The model's validity is further reinforced by the fact that NTG-induced attacks can be aborted by established anti-migraine drugs such as triptans and CGRP receptor antagonists.
Our NTG-induced migraine models allow for the detailed study of:
- Nociceptive Hypersensitivity: Assessing mechanical (e.g., Von Frey), thermal (e.g., Hargreaves), and chemical allodynia.
- Behavioral Phenotypes: Quantifying grimace scales, face grooming, and anxiety-like behaviors (e.g., elevated plus maze, open field tests).
- Neuroinflammatory Responses: Analyzing cFos immunoreactivity, neuronal nitric oxide synthase (nNOS), inducible nitric oxide synthase (iNOS) expression, and the activation of key signaling pathways like NF-κB in relevant brain regions (e.g., trigeminal nucleus caudalis).
What We Can Offer
At CBL, our NTG model development service is designed to provide you with unparalleled support and precision for your preclinical research. We understand that every project has unique requirements, and our offerings are built to deliver customized, high-quality solutions.
- Tailored Model Development: We don't just offer standard models; we provide one-stop customized NTG model development from initial consultation to final reporting. This includes adapting the model to specific research questions, ensuring it aligns perfectly with your therapeutic area, whether it's migraine, cardiovascular, or related indications.
- Optimized Study Execution: Benefit from our efficient upstream and downstream process development for all aspects of your preclinical study. This covers everything from precise animal handling and NTG administration protocols to advanced data acquisition and analysis, ensuring maximum efficiency and data integrity.
- Scalable Research Capabilities: Our state-of-the-art vivarium facilities and robust infrastructure allow for scalable studies of different volumes, accommodating various group sizes and experimental designs to meet your project's scope.
- Uncompromising Quality Assurance: We operate under a well-established quality system, integrating Quality-by-Design (QbD) principles and process analytical techniques (PAT) throughout the entire model development and assessment process. This guarantees the highest standards of data reliability and reproducibility.
- Model Stability and Reliability: We guarantee the stability and consistency of our NTG models across various experimental conditions, including chronic administration protocols. This ensures that the observed phenotypes are robust and reliable for evaluating your therapeutic candidates.
- Advanced Quality Control: We utilize high-standard quality control tools to quantify and evaluate the quality of all collected data and the overall performance of the models, providing you with confidence in your results.
Related Services
To further support your drug discovery and development efforts, CBL offers a suite of complementary services that can be integrated with our NTG model development service:
- In Vitro Assay Development & Screening
- Acute Pain Models
- Inflammatory Pain Models
- Biomarker Development & Validation
- Neuroinflammation Studies
Ready to discuss your project or learn more about how our NTG model development service can benefit your research? Our expert team is here to assist you.
Contact Our Team for More Information and to Discuss Your Project.
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)